Fluoresceína Novartis injection is used to help certain parts of the eye (eg, retina, iris) become more visible during eye medical procedures.
Fluoresceína Novartis is to be given only by or under the direct supervision of your doctor.
Fluoresceína Novartis indications
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored
Oral
Assessment of exocrine pancreatic function
Adult: 348.5 mg Fluoresceína Novartis dilaurate (equivalent to 0.5 mmol of Fluoresceína Novartis), given with meal. Collect urine for the next 10 hour. A control dose of 188.14 mg Fluoresceína Novartis Na (equivalent to 0.5 mmol of Fluoresceína Novartis) is given the following day under the same conditions.
Intravenous
Angioscopy of the retinal and iris vasculature
Adult: 500 mg (as a 10% or 25% soln) over 5-10 sec into the antecubital vein. May also be given via oral admin at 25 mg/kg using Fluoresceína Novartis sod.
Child: 7.5 mg/kg.
Ophthalmic
Detection of corneal lesions and foreign bodies; Aid in the fitting of hard contact lenses; Diagnostic ophthalmic procedures
Adult: Apply 1% or 2% solution as eye drops or as sterile papers impregnated with Fluoresceína Novartis sodium. May also be given in combination with a local anaesthetic: as a 0.25% solution with oxybuprocaine HCl or proxymetacaine HCl.
Fluoresceína Novartis description
sponsored
A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs and cosmetics. (From Merck Index, 12th ed; American Medical Association Drug Evaluations; 1995, p2275)
Fluoresceína Novartis dosage
The normal adult dose of Fluoresceína Novartis® (Fluoresceína Novartis injection, USP) 10% is 500 mg (100 mg/mL) via intravenous administration.
For children, the dose should be calculated on the basis of 35 mg for each ten pounds of body weight (7.7 mg/kg body weight).
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Do not mix or dilute with other solutions or drugs. Flush intravenous cannulas before and after drugs are injected to avoid physical incompatibility reactions.
Inject the dose rapidly (1 mL per second is normally recommended) into the antecubital vein, after taking precautions to avoid extravasation. A syringe, filled with Fluoresceína Novartis® (Fluoresceína Novartis injection, USP) 10%, may be attached to transparent tubing and a 23 gauge butterfly needle for injection. Insert the needle and draw the patient's blood to the hub of the syringe so that a small air bubble separates the patient's blood in the tubing from the Fluoresceína Novartis. With the room lights on, slowly inject the blood back into the vein while watching the skin over the needle tip. If the needle has extravasated, the patient's blood will be seen to bulge the skin and the injection should be stopped before any Fluoresceína Novartis is injected. When assured that extravasation has not occurred, the room light may be turned off and the Fluoresceína Novartis injection completed. Luminescence usually appears in the retina and choroidal vessels in 7 to 14 seconds and can be observed by standard viewing equipment.
Reduction in dose from 5 ml to 2 ml of Fluoresceína Novartis® (Fluoresceína Novartis injection, USP) 10% may be appropriate in cases when a highly sensitive imaging system e.g., scanning laser ophthalmoscope is used.
How supplied
Fluoresceína Novartis® (Fluoresceína Novartis injection, USP) 10% is supplied in a single-use 5 mL glass vial with a gray FluroTec coated chlorobutyl (latex free) stopper and purple flip-off aluminum seal. It contains a sterile, red-orange solution of Fluoresceína Novartis sodium.
NDC 0065-0092-65
Storage
Store at 2°- 25°C (36°- 77°F).
Do Not Freeze
ALCON LABORATORIES, INC. Fort Worth, Texas 76134 USA. Revised: July 2011
The most common reaction is temporary yellowish discoloration of the skin and urine. Urine may attain a bright yellow color. Discoloration of the skin usually fades in 6 to 12 hours and usually fades in urine in 24 to 36 hours.
Gastrointestinal Reactions
Nausea, vomiting, and gastrointestinal distress are common adverse events. A strong taste may develop after injection.
Hypersensitivity Reactions
Symptoms and signs of hypersensitivity have occurred. Generalized hives and itching, bronchospasm and anaphylaxis have been reported. Rare cases of death have been reported..
Cardiopulmonary Reactions
Cardiac arrest, basilar artery ischemia, severe shock and death may occur rarely.
Neurologic Reactions
Headache may occur. Convulsions and syncope may rarely occur following injection.
Thrombophlebitis
Thrombophlebitis at the injection site has been reported. Extravasation of the solution at the injection site causes intense pain at the site and a dull aching pain in the injected arm..
Fluoresceína Novartis contraindications
sponsored
Fluoresceína Novartis® Injection 10% is contraindicated in patients with known hypersensitivity to Fluoresceína Novartis sodium or any other ingredients in this product. Rare cases of death due to anaphylaxis have been reported..
Fluoresceína Novartis sodium can induce serious intolerance reactions. These reactions of intolerance are always unpredictable but they are more frequent in patients who have previously experienced an adverse reaction after Fluoresceína Novartis injection (symptoms other than nausea and vomiting) or in patients with history of allergy such as food or drug induced urticaria, asthma, eczema, allergic rhinitis.
Detailed questioning of each patient is recommended before the angiography to evaluate any prior history of allergy.
Active ingredient matches for Fluoresceína Novartis:
DailyMed. "FLUORESCEIN SODIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
The results of a survey conducted on ndrugs.com for Fluoresceína Novartis are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Fluoresceína Novartis. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
User reports
Consumer reported useful
No survey data has been collected yet
Consumer reported price estimates
No survey data has been collected yet
Consumer reported time for results
No survey data has been collected yet
1 consumer reported age
Users
%
46-60
1
100.0%
Consumer reviews
There are no reviews yet. Be the first to write one!
